Journal of Oncology Research and Treatment
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Oncol Res Treat,

MiR-124 could Inhibit CD151 Overexpression Associated with Non-Small Cell Lung Carcinoma Progression

Ke Li1, Fengdi Hu2, Chunxiang Luo3 and Jiangqiang Zhang4*
1Department of Cancer Biotherapy, Kunming Medical University, Kunming, China
2Department of Digestive Oncology, Kunming Medical University, Kunming, China
3Department of Medical Oncology, Kunming Medical University, Kunming, China
4Department of Education, College of Biology and Chemistry, Puer University, Puer, China
*Corresponding Author : Jiangqiang Zhang, Department of Education, College of Biology and Chemistry, Puer University, Puer, China, Tel: 13432266470, Email: drjqzhang@126.com

Received Date: Oct 21, 2022 / Published Date: Feb 13, 2023

Abstract

Background: CD151 is a member of the transmembrane 4 super families and has been reported to be involved in cell adherence and migration. It has been reported that the overexpression of CD151 and the down regulation of miR-124 are all related to the progression of Non-Small Cell Lung Cancer (NSCLC). However, whether there is a regulatory relationship between them has not been examined. The purpose of this study is to further explore whether there is a correlation between the expression of CD151 and miR-124 in NSCLC.

Methods: The expression of CD151 and its functional partner α3β1 in NSCLC clinical tissue was detected by immunohistochemistry. The expression of miR-124 in lung tumor tissues and serums of NSCLC patients was detected by qPCR. The targeting of CD151 mRNA by miR-124 was confirmed by the dual luciferase reporter system. Cell migration and invasion were verified by scratch wound healing and transwell invasion assay.

Results: CD151 and α3β1 expression were up regulated, while miR-124 expression in the NSCLC group was decreased compared to that in the benign lesion group. Moreover, CD151 positive expression was associated with poor survival of NSCLC patients. MiR-124 targeted the 3’UTR of CD151 mRNA and regulated its expression. Knockdown of CD151 expression with CD151 shRNA or miR-124 mimics inhibited the migration and invasion of the A549 cell line.

Conclusion: The results indicated that up regulated miR-124 could inhibit CD151 overexpression, which is associated with NSCLC progression.

Keywords: CD151; α3β1; MiR-124; Non-small cell lung cancer; Cell migration

Citation: Li K, Hu F, Luo C, Zhang J (2023) MiR-124 could Inhibit CD151 Overexpression Associated with Non-Small Cell Lung Carcinoma Progression. J Oncol Res Treat 08: 203

Copyright: © 2023 Li K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Top